Abemaciclib plus fulvestrant in hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer in premenopausal women: subgroup analysis from the MONARCH 2 trial.
Breast Cancer Res
; 23(1): 87, 2021 08 23.
Article
in En
| MEDLINE
| ID: mdl-34425869
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Benzimidazoles
/
Breast Neoplasms
/
Antineoplastic Combined Chemotherapy Protocols
/
Fulvestrant
/
Aminopyridines
Type of study:
Clinical_trials
Limits:
Adult
/
Female
/
Humans
/
Middle aged
Language:
En
Journal:
Breast Cancer Res
Journal subject:
NEOPLASIAS
Year:
2021
Type:
Article
Affiliation country:
Belgium